{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T09:10:44Z","timestamp":1780564244788,"version":"3.54.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.urology.2026.03.002","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T16:43:47Z","timestamp":1773161027000},"page":"42-48","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Patient-reported Psychological and Prostate Cancer-specific Functional Outcomes Among Men With Low-risk Prostate Cancer Two Years After Diagnosis: The PREPARE Prospective Cohort Study"],"prefix":"10.1016","volume":"212","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2374-8719","authenticated-orcid":false,"given":"Kimberly M.","family":"Davis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Luta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard M.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Lobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasiliki","family":"Zotou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold L.","family":"Potosky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin G.","family":"Sanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Penson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzin","family":"Khosrow-Khavar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac J.","family":"Ergas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen K.","family":"Van Den Eeden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn L.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2026.03.002_bib1","unstructured":"Surveillance Research Program, National Cancer Institute: SEER*Explorer: An interactive website for SEER cancer statistics [Internet] [Internet], 2024 Available from: \u3008https:\/\/seer.cancer.gov\/statistics-network\/explorer\/\u3009."},{"key":"10.1016\/j.urology.2026.03.002_bib2","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.eururo.2013.12.062","article-title":"Overdiagnosis and overtreatment of prostate cancer","volume":"65","author":"Loeb","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2026.03.002_bib3","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/jnci\/djp001","article-title":"Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context","volume":"101","author":"Draisma","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urology.2026.03.002_bib4","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1200\/JCO.2009.26.0133","article-title":"Time trends and local variation in primary treatment of localized prostate cancer","volume":"28","author":"Cooperberg","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urology.2026.03.002_bib5","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1001\/jama.2018.3712","article-title":"Prostate-specific antigen-based screening for prostate cancer: evidence report and systematic review for the US preventive services task force","volume":"319","author":"Fenton","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.urology.2026.03.002_bib6","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.juro.2017.11.095","article-title":"Clinically localized prostate cancer: AUA\/ASTRO\/SUO Guideline. Part I: risk stratification, shared decision making, and care options","volume":"199","author":"Sanda","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2026.03.002_bib7","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.1439","article-title":"Time trends and variation in the use of active surveillance for management of low-risk prostate cancer in the US","volume":"6","author":"Cooperberg","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.urology.2026.03.002_bib8","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa2214122","article-title":"Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer","volume":"388","author":"Hamdy","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urology.2026.03.002_bib9","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1001\/jama.2017.1704","article-title":"Association between radiation therapy, surgery, or observation for localized prostate cancer and patient-reported outcomes after 3 years","volume":"317","author":"Barocas","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.urology.2026.03.002_bib10","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1001\/jama.2023.26491","article-title":"Functional outcomes after localized prostate cancer treatment","volume":"331","author":"Al Hussein Al Awamlh","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.urology.2026.03.002_bib11","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1001\/jama.2024.6695","article-title":"Long-term outcomes in patients using protocol-directed active surveillance for prostate cancer","volume":"331","author":"Newcomb","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.urology.2026.03.002_bib12","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.eururo.2016.06.007","article-title":"A decade of active surveillance in the PRIAS study: an update and evaluation of the criteria used to recommend a switch to active treatment","volume":"70","author":"Bokhorst","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2026.03.002_bib13","doi-asserted-by":"crossref","first-page":"432.e1","DOI":"10.1016\/j.urolonc.2020.11.024","article-title":"Trends in the use of active surveillance and treatments in Medicare beneficiaries diagnosed with localized prostate cancer","volume":"39","author":"Liu","year":"2021","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urology.2026.03.002_bib14","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.eururo.2018.02.026","article-title":"Factors influencing men\u2019s choice of and adherence to active surveillance for low-risk prostate cancer: a mixed-method systematic review","volume":"74","author":"Kinsella","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2026.03.002_bib15","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1158\/1055-9965.EPI-15-1079","article-title":"Treatment preferences for active surveillance versus active treatment among men with low-risk prostate cancer","volume":"25","author":"Taylor","year":"2016","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.urology.2026.03.002_bib16","first-page":"637","article-title":"How does active surveillance for prostate cancer affect quality of life? A systematic review","volume":"67","author":"Bellardita","year":"2015","journal-title":"Eur\u00a0Urol"},{"key":"10.1016\/j.urology.2026.03.002_bib17","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ctrv.2014.11.001","article-title":"Wellbeing during active surveillance for localised prostate cancer: a systematic review of psychological morbidity and quality of life","volume":"41","author":"Carter","year":"2015","journal-title":"Cancer Treat\u00a0Rev"},{"key":"10.1016\/j.urology.2026.03.002_bib18","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa1606221","article-title":"Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer","volume":"375","author":"Donovan","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urology.2026.03.002_bib19","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/JU.0000000000002370","article-title":"Association between treatment for localized prostate cancer and mental health outcomes","volume":"207","author":"Luckenbaugh","year":"2022","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2026.03.002_bib20","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/bco2.124","article-title":"Psychological predictors of delayed active treatment following active surveillance for low-risk prostate cancer: the Patient REported outcomes for Prostate cARE prospective cohort study","volume":"3","author":"Taylor","year":"2022","journal-title":"BJUI Compass"},{"key":"10.1016\/j.urology.2026.03.002_bib21","doi-asserted-by":"crossref","unstructured":"Ware J.E., Kosinski M., Keller S.D.: A 12-Item Short-Form Health Survey: Construction of Scales and Preliminary Tests of Reliability and Validity. Medical Care 34:220, 199631.","DOI":"10.1097\/00005650-199603000-00003"},{"key":"10.1016\/j.urology.2026.03.002_bib22","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med Care"},{"key":"10.1016\/j.urology.2026.03.002_bib23","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s11136-009-9496-9","article-title":"Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items","volume":"18","author":"Hays","year":"2009","journal-title":"Qual Life Res"},{"key":"10.1016\/j.urology.2026.03.002_bib24","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1200\/JCO.2003.02.115","article-title":"Patients\u2019 perceptions of quality of life after treatment for early prostate cancer","volume":"21","author":"Clark","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urology.2026.03.002_bib25","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.urology.2010.01.027","article-title":"Development and validation of an abbreviated version of the expanded prostate cancer index composite instrument (EPIC-26) for measuring health-related quality of life among prostate cancer survivors","volume":"76","author":"Szymanski","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.urology.2026.03.002_bib26","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/01.MLR.0000062554.74615.4C","article-title":"Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation","volume":"41","author":"Norman","year":"2003","journal-title":"Med Care"},{"key":"10.1016\/j.urology.2026.03.002_bib27","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1001\/jama.2019.20675","article-title":"Patient-reported outcomes through 5 years for active surveillance, surgery, brachytherapy, or external beam radiation with or without androgen deprivation therapy for localized prostate cancer","volume":"323","author":"Hoffman","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.urology.2026.03.002_bib28","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.eururo.2018.10.025","article-title":"Reasons for discontinuing active surveillance: assessment of 21 centres in 12 countries in the Movember GAP3 consortium","volume":"75","author":"Van Hemelrijck","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2026.03.002_bib29","first-page":"4699","article-title":"What interventions affect the psychosocial burden experienced by prostate cancer patients undergoing active surveillance? A scoping review","volume":"30","author":"Donachie","year":"2022","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.urology.2026.03.002_bib30","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/JU.0000000000003491","article-title":"Early detection of prostate cancer: AUA\/SUO guideline part i: prostate cancer screening","volume":"210","author":"Wei","year":"2023","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2026.03.002_bib31","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1200\/JCO.19.02768","article-title":"Molecular biomarkers in localized prostate cancer: ASCO guideline","volume":"38","author":"Eggener","year":"2020","journal-title":"J Clin Oncol"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429526001548?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429526001548?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T08:54:34Z","timestamp":1780563274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429526001548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":31,"alternative-id":["S0090429526001548"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2026.03.002","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient-reported Psychological and Prostate Cancer-specific Functional Outcomes Among Men With Low-risk Prostate Cancer Two Years After Diagnosis: The PREPARE Prospective Cohort Study","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2026.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}